Director/PDMR Shareholding

RNS Number : 7294I

Sagentia Group PLC

24 November 2008

 



SAGENTIA GROUP PLC

('Sagentia' or the 'Company')

Grant of options

Sagentia (AIM:SAG.L) announces that, in line with the management incentivisation strategy outlined in the Company's admission document published on 11 June 2008, it has, on 21/11/2008, granted various options over ordinary shares in its share capital, to directors and employees of the Company.

Options over 454,467 ordinary shares have been granted to directors of the Company as set out below, as a replacement for options granted under the Sagentia Group AG New Executive Share Option Scheme. As a result of this grant, and of the grant of similar options to non board level employees described below, the corresponding options granted under the Sagentia Group AG New Executive Share Option Scheme have been cancelled. Other Sagentia Group AG options, issued under the Sagentia Group AG Old Executive Share Option Scheme have become exercisable following the change of ownership in Sagentia Group AG but will expire at the end of December 2008. After 31/12/2008, no further options will be outstanding on the share capital of Sagentia Group AG. The Sagentia Group plc options are exercisable after two years from the date of grant of the original options granted under the Sagentia Group AG New Executive Share Option Scheme (the 'Original Date of Grant') for a period of eight years at an exercise price of 1 Swiss Franc per share (to be converted into UK pence at the prevailing exchange rate at the time of exercise). 

Director	No. of options	Original Date of Grant
Alistair Brown	147,079	24/12/2007
Alistair Brown	50,000	19/3/2008
Daniel Flicos	147,079	24/12/2007
Guy McCarthy	110,309	24/12/2007

In addition, options over a further 606,769 ordinary shares have been granted to directors of the Company under both the Sagentia Group plc Executive Share Option approved and unapproved schemes. These options are exercisable at an exercise price of 17.5 pence per share for a period of seven years from 21/11/2011. 

Director	No. of options
Options granted under the approved scheme
Alistair Brown	171,428
Daniel Flicos	160,000
Guy McCarthy	171,428
Options granted under the unapproved scheme
Alistair Brown	78,572
Guy McCarthy	25,341

In addition, options over 1,503,250 ordinary shares, of which

• 522,365 are in replacement of options granted under the Sagentia Group AG New Executive Share Option Scheme and are exercisable at the UK£ equivalent of 1 Swiss Franc per share and

•  980,885 are exercisable at 17.5 pence per share,

have also been granted to other non board level employees.

Save for the above, the directors' beneficial interests in the share capital of the Company remain unchanged and as previously announced.

Enquiries:

Sagentia Group PLC and Sagentia Group AG:

Dr Alistair Brown     [phone]

Guy McCarthy 

Arbuthnot Securities:

John Prior         [phone]

Antonio Bossi

Hansard Group 

Vikki Krause         [phone]

www.hansardgroup.co.uk

About Sagentia 

Sagentia is a leading international technology consulting and IP licensing organisation with a reputation for successfully commercialising emerging science and technology. Sagentia creates, develops and delivers business opportunities, products and services for its clients.

Established in 1986, Sagentia operates in six global market sectors - medical, industrial products, consumer products, chemicals, materials & energy, telecoms & media and public sector - developing new technologies, products and services that change the basis of competition. The company also assists business leaders to create strategies for technology, innovation and growth.  

Sagentia has more than 200 employees and has resources situated in state-of-the-art facilities in Europe, the USA, and China. Sagentia is listed on AIM (SAG.L), the growth market of the London Stock Exchange.

www.sagentia.com/investors

[e-mail] 

 

END

 

 

RDSILFSDLDLLFIT